Owing to this finding and the loss of EBF1 expression in EB tumors, we investigated whether loss of heterozygosity occurs in EB tumors similar to EBF1 genetic lesions found in a subset of high-risk pediatric B-ALL. This evidence concerns the gene EBF1 and precursor B-cell acute lymphoblastic leukemia.